INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹111
- High
- ₹114
- 52 Week Low
- ₹110
- 52 Week High
- ₹277
- Open Price₹114
- Previous Close₹115
- Volume4,029
- 50 DMA₹126.25
- 100 DMA₹134.70
- 200 DMA₹152.75
Investment Returns
- Over 1 Month -10.29%
- Over 3 Month -15.41%
- Over 6 Month -27.61%
- Over 1 Year -54.15%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.4
- PEG Ratio
- 0.3
- Market Cap Cr
- 226
- P/B Ratio
- 2.6
- Average True Range
- 6.01
- EPS
- 8.43
- Dividend Yield
- 0
- MACD Signal
- -2.21
- RSI
- 35.01
- MFI
- 82.95
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹112.50
-0.5
(-0.44%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹121.36
- 50 Day
- ₹126.25
- 100 Day
- ₹134.70
- 200 Day
- ₹152.75
Resistance and Support
114.17
- R3 118.83
- R2 117.67
- R1 115.33
- S1 111.83
- S2 110.67
- S3 108.33
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-11 | Quarterly Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹112 As on 12 January, 2026 | 13:01
The Market Cap of Indo US Bio-Tech is ₹225.6 Cr As on 12 January, 2026 | 13:01
The P/E ratio of Indo US Bio-Tech is 13.4 As on 12 January, 2026 | 13:01
The PB ratio of Indo US Bio-Tech is 2.6 As on 12 January, 2026 | 13:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.